These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17011495)

  • 21. From oogenesis through gastrulation: developmental regulation of apoptosis.
    Greenwood J; Gautier J
    Semin Cell Dev Biol; 2005 Apr; 16(2):215-24. PubMed ID: 15797832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cullin-5 mutants reveal collective sensing of the nucleocytoplasmic ratio in Drosophila embryogenesis.
    Hayden L; Chao A; Deneke VE; Vergassola M; Puliafito A; Di Talia S
    Curr Biol; 2022 May; 32(9):2084-2092.e4. PubMed ID: 35334230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of cell cycles in Drosophila development: intrinsic and extrinsic cues.
    Lee LA; Orr-Weaver TL
    Annu Rev Genet; 2003; 37():545-78. PubMed ID: 14616073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for radiation sensitizers of Drosophila checkpoint mutants.
    Gladstone M; Su TT
    Methods Mol Biol; 2011; 782():105-17. PubMed ID: 21870288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safeguarding genetic information in Drosophila.
    Su TT
    Chromosoma; 2011 Dec; 120(6):547-55. PubMed ID: 21927823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Checkpoints: controls that ensure the order of cell cycle events.
    Hartwell LH; Weinert TA
    Science; 1989 Nov; 246(4930):629-34. PubMed ID: 2683079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developmental modification of the Drosophila cell cycle.
    Orr-Weaver TL
    Trends Genet; 1994 Sep; 10(9):321-7. PubMed ID: 7974746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal cell cycle progression requires negative regulation of E2F1 by Groucho during S phase and its relief at G2 phase.
    Bar-Cohen S; Martínez Quiles ML; Baskin A; Dawud R; Jennings BH; Paroush Z
    Development; 2023 Jun; 150(11):. PubMed ID: 37260146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing CHK1 inhibitor lethality in glioblastoma.
    Tang Y; Dai Y; Grant S; Dent P
    Cancer Biol Ther; 2012 Apr; 13(6):379-88. PubMed ID: 22313687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The yeast mitogen-activated protein kinase Slt2 is involved in the cellular response to genotoxic stress.
    Soriano-Carot M; Bañó MC; Igual JC
    Cell Div; 2012 Feb; 7():1. PubMed ID: 22296825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular signal-regulated kinases modulate DNA damage response - a contributing factor to using MEK inhibitors in cancer therapy.
    Wei F; Yan J; Tang D
    Curr Med Chem; 2011; 18(35):5476-82. PubMed ID: 22087839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2.
    Pei XY; Dai Y; Youssefian LE; Chen S; Bodie WW; Takabatake Y; Felthousen J; Almenara JA; Kramer LB; Dent P; Grant S
    Blood; 2011 Nov; 118(19):5189-200. PubMed ID: 21911831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ARF triggers cell G1 arrest by a P53 independent ERK pathway.
    Du H; Yao W; Fang M; Wu D
    Mol Cell Biochem; 2011 Nov; 357(1-2):415-22. PubMed ID: 21660463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cycle.
    Dent P; Tang Y; Yacoub A; Dai Y; Fisher PB; Grant S
    Mol Interv; 2011 Apr; 11(2):133-40. PubMed ID: 21540473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet activating factor blocks interkinetic nuclear migration in retinal progenitors through an arrest of the cell cycle at the S/G2 transition.
    Fragel-Madeira L; Meletti T; Mariante RM; Monteiro RQ; Einicker-Lamas M; Bernardo RR; Lopes AH; Linden R
    PLoS One; 2011 Jan; 6(1):e16058. PubMed ID: 21298035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unphosphorylated STAT and heterochromatin protect genome stability.
    Yan SJ; Lim SJ; Shi S; Dutta P; Li WX
    FASEB J; 2011 Jan; 25(1):232-41. PubMed ID: 20847228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Four-dimensional dynamics of MAPK information processing systems.
    Kholodenko BN; Birtwistle MR
    Wiley Interdiscip Rev Syst Biol Med; 2009; 1(1):28-44. PubMed ID: 20182652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral oncolysis that targets Raf-1 signaling control of nuclear transport.
    Riolobos L; Valle N; Hernando E; Maroto B; Kann M; Almendral JM
    J Virol; 2010 Feb; 84(4):2090-9. PubMed ID: 19939915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor-induced DNA damage in vitro and in vivo in human multiple myeloma cells.
    Dai Y; Chen S; Pei XY; Almenara JA; Kramer LB; Venditti CA; Dent P; Grant S
    Blood; 2008 Sep; 112(6):2439-49. PubMed ID: 18614762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The candidate MAP kinase phosphorylation substrate DPL-1 (DP) promotes expression of the MAP kinase phosphatase LIP-1 in C. elegans germ cells.
    Lin B; Reinke V
    Dev Biol; 2008 Apr; 316(1):50-61. PubMed ID: 18304523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.